Mia Wadelius
Uppsala University(SE)Science for Life Laboratory(SE)Karolinska Institutet(SE)MRC London Institute of Medical Sciences(GB)Imperial College London(GB)Medical Research Council(GB)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Hormonal Regulation and Hypertension, Atrial Fibrillation Management and Outcomes, Drug Transport and Resistance Mechanisms, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → A Randomized Trial of Genotype-Guided Dosing of Warfarin(2013)804 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update(2017)673 cited
- → Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing(2011)644 cited
- → A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose(2009)637 cited
- → The largest prospective warfarin-treated cohort supports genetic forecasting(2008)551 cited
- → Common VKORC1 and GGCX polymorphisms associated with warfarin dose(2005)466 cited